Amicus Therapeutics
FOLD
FOLD
202 hedge funds and large institutions have $2.66B invested in Amicus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 70 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 70
9% less funds holding
Funds holding: 223 → 202 (-21)
39% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 49
Holders
202
Holding in Top 10
7
Calls
$13.5M
Puts
$4.36M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$36.8M | |
| 3 | +$34.7M | |
| 4 |
DM
Deerfield Management
New York
|
+$30.1M |
| 5 |
JPMorgan Chase & Co
New York
|
+$25.6M |
Top Sellers
| 1 | -$48.3M | |
| 2 | -$19.4M | |
| 3 | -$16.6M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$15.6M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$13.5M |